September 30, 2022
Qnovia, Inc. Raises $17 Million in Series A Funding to Advance Its Inhalable Therapeutics Pipeline
LOS ANGELES–(BUSINESS WIRE)–Qnovia, Inc. (Qnovia), a pharma company developing inhaled...
‘Too many Respiras’: Smoking cessation health tech company throws out overused name as it rebrands to Qnovia
How do you deal with a problem like Respira? For this health tech company, which must compete with...